Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.

Source:http://linkedlifedata.com/resource/pubmed/id/10871161

Download in:

View as

General Info

PMID
10871161